Every medication on an older adult’s list was prescribed for a reason that made sense at the time. That’s precisely what makes deprescribing hard: nothing on the list is there by accident, yet the person taking it today is often not the same person the prescription was written for.
A statin started at 68 for primary prevention, a sleep aid was added after a stressful year, and a proton pump inhibitor meant to last eight weeks was now in its sixth year; each decision was reasonable in its moment. The problem is that medication lists rarely get revisited with the same rigor they were built with.
At Primary Medical Care Center in Miami, deprescribing is the discipline of closing that gap.
Triage: Start With What Could Hurt Them Fastest
Not every medication deserves equal scrutiny in the same visit, and a full-scale review of every drug at once isn’t realistic or necessary. The smarter approach includes identifying the categories where harm tends to arrive suddenly and severely, often before anyone connects it back to the medication itself.
Several drug classes deserve first attention specifically because their downside shows up as a fall, an ED visit, or new confusion rather than a lab value trending the wrong direction:
- Sedative-hypnotics and benzodiazepines: Strongly associated with falls, cognitive impairment, and delirium in older adults
- Anticholinergics: Cumulative anticholinergic burden drives confusion and functional decline, often missed because individual drugs seem low-risk.
- Opioids and muscle relaxants: Fall and sedation risk compounds when combined with other CNS-active drugs.
- Duplicate therapies: Accumulated across multiple prescribers, often unnoticed until a formal reconciliation
- Medications that worsen orthostatic hypotension: A frequently overlooked contributor to falls in this population
- Hypoglycemic agents—deserving renewed scrutiny any time appetite, weight, renal function, or cognition shifts, since the risk profile of tight glycemic control changes with all four
Established tools exist specifically to support this triage; the Beers Criteria and the STOPP/START criteria are the two most widely used frameworks in Miami for flagging potentially inappropriate medications in older adults, and both are worth having on hand as a starting checklist rather than working from memory alone.
But a flag on a list is an invitation to investigate, not a verdict. Whether a given medication is actually dangerous for this patient depends on a cluster of individual factors (renal function, baseline cognition, fall history, blood pressure trends, etc.).
The same drug can be low-risk for one patient and a genuine hazard for another; the triage list shows where to look, not what to conclude.
Weigh the Wait Against the Time Left
Some medications work immediately. Others are a bet on the future: a statin, a bone density medication, and a screening-driven preventive therapy, all designed to prevent an event that might occur years down the line.
That distinction, often called time-to-benefit, becomes one of the most important variables in an older adult with advancing multimorbidity or a shortened life expectancy.
Weighing the situation well means holding several things at once: how well the underlying condition is currently controlled, what side effects the patient is tolerating (or not disclosing), how heavy the overall pill burden has become, and, perhaps most important, what the patient themselves is actually willing to keep doing.
A patient who says plainly that they’d rather feel better today than optimize a risk they may never live to face has given you information that belongs in the decision, not just in a chart note.
Change One Thing, Then Watch Carefully
Once a target is identified, the instinct to fix everything in one visit needs to be resisted. Stopping multiple medications simultaneously destroys your ability to attribute what happens next; if a symptom emerges, a rebound effect appears, or a chronic condition destabilizes, you won’t know which change caused it. Deprescribing is not a single event; it’s a sequence.
The practical sequence looks like this:
- Identify the single medication most likely to cause harm or least likely to still be helping.
- Have an explicit conversation with the patient and, where relevant, their caregiver.
- Taper or stop with a defined monitoring window, not an open-ended “let’s see what happens.”
- Be specific about what to watch for, when to call, and under what circumstances the medication would be restarted.
Benzodiazepines, opioids, beta-blockers, corticosteroids, and certain antidepressants carry real withdrawal or rebound risk and require a deliberate, gradual taper. Others can be discontinued more directly, depending on the specific drug, dose, duration of use, and the broader clinical picture. Treating every discontinuation with the same caution, or the same casualness, is itself a source of avoidable harm.
Deprescribing Belongs in Routine Care, Not Crisis Response
The single biggest reason deprescribing gets skipped is timing. If it’s treated as a special project reserved for a fall or hospitalization, it will keep losing to whatever is more urgent during a packed visit.
Deprescribing works far better as a standing habit, triggered by moments that already exist on the calendar: annual wellness visits, post-discharge follow-up, a new fall, unexplained confusion, unintentional weight loss, dizziness, a change in renal function, or a transition to a higher level of care.
This process is also not work one clinician should carry alone. A team-based structure makes it sustainable:
- Medical assistants can flag unusually long medication lists before the visit even starts.
- Nurses can handle structured follow-up after a taper begins.
- Pharmacists can catch duplications and dangerous combinations a chart review might miss.
- Care coordinators can manage the complexity when multiple prescribers are involved and no single person has the full picture.
None of this happens quickly, and it shouldn’t be expected to. Reducing medication burden safely requires continuity and enough trust that a patient will actually tell you when something doesn’t feel right after a change.
In care models built around long-term relationships rather than transactional visits, that continuity is precisely what makes deprescribing possible instead of theoretical.
The Point Isn’t Fewer Pills, But the Right Ones
Deprescribing done well is about keeping the medication list matched to the patient’s actual physiology, actual goals, and actual daily life, rather than to decisions made years ago under different circumstances.
The path there is consistent: find the real list, triage for the medications most likely to cause silent harm, ask whether each one still fits the patient in front of you, weigh how long a benefit will take against how much time realistically remains, change one thing at a time, and watch closely afterward.
At Primary Medical Care Center, we offer a well-structured medication system that addresses each client’s profile and physiological needs. You can make an appointment today call (305) 751-1500.